BioNxt Solutions Inc.
CNQ: BNXT.CN0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Canadian Securities Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Hugh A. D. Rogers
- Employees
- 25
- Headquarters
- Vancouver, Canada
- IPO year
- 2019
- Market cap
- CA$56.0M
- Website
- https://xphyto.com
Loading BNXT…
Loading profile data…Frequently asked questions about BNXT
What does BioNxt Solutions Inc. (BNXT.CN) do?
BioNxt Solutions Inc. operates as a bioscience company in Germany, Switzerland, Austria, Israel, and Canada. It develops drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications; and psychedelic medicine to treat mental health-related medical conditions, including depression,...
Where does BNXT.CN trade?
BioNxt Solutions Inc. (BNXT.CN) trades on the Canadian Securities Exchange.
What sector is BNXT.CN in?
BioNxt Solutions Inc. (BNXT.CN) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of BioNxt Solutions Inc.?
Hugh A. D. Rogers is the chief executive officer of BioNxt Solutions Inc. (BNXT.CN).
Where is BioNxt Solutions Inc. headquartered?
BioNxt Solutions Inc. is headquartered in Canada.
Does BNXT.CN pay a dividend?
BioNxt Solutions Inc. (BNXT.CN) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BNXT.CN go public?
BioNxt Solutions Inc. (BNXT.CN) completed its initial public offering in 2019.